dsdsa

product

Manufacturing Companies for Tofacitinib Citrate Powder - 15307-79-6 Diclofenac Sodium with USP BP Quality Standard and Ready Stock Anti-inflammatory Agent – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

We attempt for excellence, support the customers", hopes to become the top cooperation team and dominator enterprise for staff, suppliers and shoppers, realizes worth share and continual marketing for 1392275-56-7, China Melatonine Powder, Improving Sleep Melatonine, We warmly welcome clients from all around the world for almost any sort of cooperation with us to build a mutual advantage potential. We've been devoting ourselves wholeheartedly to supply consumers the very best company.
Manufacturing Companies for Tofacitinib Citrate Powder - 15307-79-6 Diclofenac Sodium with USP BP Quality Standard and Ready Stock Anti-inflammatory Agent – Yibai Detail:

Product name Diclofenac sodium
Synonyms 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid sodium salt
CAS No. 15307-79-6
Appearance A white or slightly yellowish crystalline powder, slightly hygroscopic
Molecular Formula C14H10Cl2NNaO2
Molecular Weight 318.13
Application Pharmaceutical grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

 Diclofenac Sodium CAS No.: 15307-79-6

ITEMS STANDARDS RESULTS
Appearance A white or slightly yellowish crystalline powder, slightly hygroscopic A white crystalline powder
Identification Positive Conforms
Appearance of solution 440≤0.05 Conforms
Related substances Single impurity ≤0.2% 0.14%
Total impurities ≤0.5% 0.25%
Heavy metals Conforms Conforms
Loss on drying ≤0.5% 0.25%
Assay 99.09%-101.0% 99.58%
Conclusion:   Complies with BP2015 standard. 

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Manufacturing Companies for Tofacitinib Citrate Powder - 15307-79-6 Diclofenac Sodium with USP BP Quality Standard and Ready Stock Anti-inflammatory Agent – Yibai detail pictures

Manufacturing Companies for Tofacitinib Citrate Powder - 15307-79-6 Diclofenac Sodium with USP BP Quality Standard and Ready Stock Anti-inflammatory Agent – Yibai detail pictures

Manufacturing Companies for Tofacitinib Citrate Powder - 15307-79-6 Diclofenac Sodium with USP BP Quality Standard and Ready Stock Anti-inflammatory Agent – Yibai detail pictures


Related Product Guide:

Innovation, excellent and reliability are the core values of our firm. These principles today more than ever form the basis of our success as an internationally active mid-size corporation for Manufacturing Companies for Tofacitinib Citrate Powder - 15307-79-6 Diclofenac Sodium with USP BP Quality Standard and Ready Stock Anti-inflammatory Agent – Yibai , The product will supply to all over the world, such as: Switzerland, Eindhoven, Eindhoven, We adhere to client 1st, top quality 1st, continuous improvement, mutual advantage and win-win principles. When cooperation together with the customer, we provide shoppers with the highest high-quality of service. Established good business relations using the Zimbabwe buyer inside the business, we've got established own brand and reputation. At the identical time, wholeheartedly welcome new and old prospects to our company to go to and negotiate small business.
  • The after-sale warranty service is timely and thoughtful, encounter problems can be resolved very quickly, we feel reliable and secure.
    5 Stars By Princess from Guyana - 2017.01.28 19:59
    The company can keep up with the changes in this industry market, product updates fast and the price is cheap, this is our second cooperation, it's good.
    5 Stars By Betsy from Poland - 2018.04.25 16:46
    Write your message here and send it to us